{"name":"Quest Diagnostics","slug":"quest","ticker":"DGX","exchange":"NYSE","domain":"questdiagnostics.com","description":"Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.","hq":"Secaucus, NJ","founded":1996,"employees":"57000","ceo":"Stephen H. Rusckowski","sector":"Clinical Laboratory Services","stockPrice":188.99,"stockChange":-1.86,"stockChangePercent":-0.97,"marketCap":"$20.9B","metrics":{"revenue":11278000128,"revenueGrowth":9.2,"grossMargin":33.3,"rdSpend":0,"netIncome":992000000,"cash":393000000,"dividendYield":1.8,"peRatio":20.9,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-28","type":"earnings","headline":"Quest Diagnostics Reports Fourth Quarter and Full Year 2022 Results","summary":"Quest Diagnostics reported fourth quarter and full year 2022 results, with revenue of $2.4 billion and adjusted net income of $444 million.","drugName":"","sentiment":"neutral"},{"date":"2022-08-01","type":"deal","headline":"Quest Diagnostics Acquires LabCorp's Clinical Trials Business","summary":"Quest Diagnostics acquired LabCorp's clinical trials business, expanding its capabilities in the clinical trials market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOaHFRMVJ5NnpWdzFueXpCdjlqdU4tZ2ZySk1HR0t2TUZsYmRHWG5pNk1WNmdfLWh4UC01b0gtMnU3aXk2aGhuOTVhMXNkeURwSUxFV3RHS0QzMmRDdUY0RTY1ZHgyQ2Zjb2FyaXo5QVhpRzJCN2lMZUZ0U3BJZzVOdm9NN0NWOXczdFM3eThwWWRjY2E4em5ScS1zc0xRV2xOR0JiR3FR?oc=5","date":"2026-03-22","type":"pipeline","source":"Yahoo Finance","summary":"How Guardant’s Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story - Yahoo Finance","headline":"How Guardant’s Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQQlRNby1Ua3JEU2VoVWRBb0tNdTZnaU4yVUdoeEpGdV9STTUyb3k4X3FnT3Q1eUVVckl3bDdoZzA2amNWclhiNHI5N0xzd0J1Smp2YmNZZzIzODRYYjgwczJNdDViWWhZeUtoWUNUMmRFaFhIeE5WT2pjdTNLbjlhbTQyQ1pabFE4WTAwM1FOUGxNOFQ4V0I0SjhSODBKNW1zNS10b0RDbjE2eGx6N1BwUTJJUDZLdnlRM2cyQQ?oc=5","date":"2026-03-12","type":"pipeline","source":"Stock Titan","summary":"Ex-Walgreens CEO who ran $100B Express Scripts joins Quest board - Stock Titan","headline":"Ex-Walgreens CEO who ran $100B Express Scripts joins Quest board","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPbHhkUWxWeHE3cW9jbndiQUZNeEVqd004bkxqSmdZY2lFM01NMmlsa0ZCZkRaeGIzSzdoaHJPalVZQm5VcDJLN1h2OTl4RGNUSVhzQ3Z1QnVJT3p2MEttYVhtUmo3TXp3RFJtRmgxa3V6bWlvY2NURlc4cHNwdlpGSTVRbU1xT2JIWVJob2Vtaw?oc=5","date":"2026-02-05","type":"pipeline","source":"The Motley Fool","summary":"Best Genomics Stocks of 2026: Are They Right for Your Portfolio? - The Motley Fool","headline":"Best Genomics Stocks of 2026: Are They Right for Your Portfolio?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNcWNBNDF0RzZJTERQMXRCeld6bWY4dkxsUERRZ0NKd2twaHRyMldHZF9mZ0stRzJaMV9naEpRdVVmRGVpZU1wNVFGMGRwdmxXVEV0VTAyeDR2ZkZ1WEg2aXBsNDRmSU4wMko4c0I0QXc0Z3VvcFlXbDRJcjNDT3o5TjY0MHRVN3g5LWtnVFh3?oc=5","date":"2025-10-22","type":"pipeline","source":"Yahoo Finance","summary":"Quest Diagnostics Incorporated (DGX): A Bull Case Theory - Yahoo Finance","headline":"Quest Diagnostics Incorporated (DGX): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNSlUyeVFlVGNaVFdaaWxzQUVWV3dpbEdBQnVSYUF2SkpXdDJuUHpyTml4RUtIQzhzWUVYTW84UDJIYURLclRaNVo4dWVEbjViMGN2SWtra2JtQ2E2Zi1JMERIUk0ycjVkdkNyV1dieHpROFJ0S1RjZUotSmZHUHZVLXFRV1hIRXdQOC1NNXJmRmYzVVIyX0xudHJ0eDA5UTU4Sk1vUzA5aw?oc=5","date":"2025-10-22","type":"earnings","source":"Seeking Alpha","summary":"Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead (NYSE:DGX) - Seeking Alpha","headline":"Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead (NYSE:DGX)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPcDhMbU9BVl9FakdsNjdjd0JRTG1PdXk2d3RmNWJlLTUxNE1PTXd0cDFQLTdjUjlkLXRodnJaNjVwZVlaREE0eWxZRlZZWXJab0t5MndZWjFLNFlFMTFxLVkwNENHbW1aMTBoa3o4MjVqdkF6d252Qk1qU1JTOUFRc2dfQ1JSNGEwSHBaZDdEQ3BLLTYwYUJ3dUxEQjY3NnRXVk8zNUtsMnZ3Rl9tLXc?oc=5","date":"2025-07-25","type":"pipeline","source":"The Business Journals","summary":"Quest and CVS test co-location strategy in Rhode Island - The Business Journals","headline":"Quest and CVS test co-location strategy in Rhode Island","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPdnZzaWQzQXVFZkY0UHF2NUs1VWN2cGNiSHFBbHNZMDNrTUp3OVFwUEw0Y0o3dUNrbndkQXNyQUszUG5WeXZ3eTV5cEhEZHNPTm10MlVfSGxTa2pzV0VjUEMtWlpGSDNzM1pwYTFaWHY5am96N0NOMnVGQ2dzUEhhX1NFeV84bHlVYksxMllFd250ZUxPMnBLMjVtTEY0QkZZTVFtUGF4bDJ5WG5KaEVlTE43aGtMR0lQa2RxV1VaakdNdzUyOHdCWHBqb3RPalE?oc=5","date":"2025-04-29","type":"regulatory","source":"Reuters","summary":"Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters","headline":"Labcorp beats quarterly profit estimate on diagnostic test demand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSmg5ZEc4Q1lSZy04cHd2RE1XcE5HOE52NUxUS3pBdC1yQ3kzbkktWXBNb1VkbmdSNzI0bm9EclNoQUR3NjZlWV9KcUxOME1Oc3lFckVWYXV5UndxdW10RUNMNFlNT1BVSVJ5VjltaGE0NVdIbmt6SDBlNkJJWWJ6d0M3SFRWX3pjN0NJcDd4NU9tRG83ZHFoVWhPcUh0aHRtNTJNRUF3R3N4Y2Exd0lDaGtXcVpTZkFaeEN6ZjJFQkFQUQ?oc=5","date":"2024-07-25","type":"pipeline","source":"BD Newsroom","summary":"BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases - BD Newsroom","headline":"BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQSnZTNDBFdlJQdWJZRmRFSzZ4TkhFS2dkNmlfalg0Q3lmZzVpeHUtNXNjUGtTUTA3TlAwQmtyX1lUb1FlMjdGQmtVQnZ3NXMwV3VZZlJ1NE5XQnpOT29KRS10UnVGMlBSZE9pUC1ZY2t0Q3kxNEQtRU91RjI1SUkzWHJORU01Q0xIYTd4X1dybENSX3R6VzRYVUo4Q2VaYTdVLXhyVWhVbVJITXh2R3BtR2JNUWZldjJPVVprd3FiQ1U1SEpLWlg5cVZB?oc=5","date":"2023-07-31","type":"pipeline","source":"Reuters","summary":"Quest Diagnostics launches Alzheimer's blood test for consumers - Reuters","headline":"Quest Diagnostics launches Alzheimer's blood test for consumers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNLWFJb2ctaHl5T0RlYWdWdXlnaXptWnlQblhybEJQQW4waTEwRXVMdDdNZEVRZ0hlMlVMcElTS3Nhd3QtaHpSaC1RNzZQbFJoN3hXM2xZZVNRRktOU0FxUGhNZ1I2MWpzTDN0em40NnZPYWVab0o4YU1LcFFCMUR0bEhFblpGdWZTcm5jaU1OYjdWb0ZpOXRFNHl2eEZIcGlIRFpVQmpJODJBcEp3cG9Ld2FZQ0pjOU1TczZnM21mRE9hQ0gxYWtIN20yUGVLR09DMC1Yb05TRWxfbUNUZDYwSkVONW1mSDgyTER4dHhGeVdodw?oc=5","date":"2022-10-13","type":"pipeline","source":"PR Newswire","summary":"Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence - PR Newswire","headline":"Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE5QZ0QxSWIxaWpVbWtEVllaQWowZkU2TkZtLXdhMnRGZjdpQWpYeC1GTXh3eExoU3RHUWtUOHlicjdmSmdPandEQVhhS19fUm4zVmx0SW9TZXI4Zw?oc=5","date":"2020-05-18","type":"pipeline","source":"fortune.com","summary":"Quest Diagnostics (DGX): Company Profile, Stock Price, News, Rankings - fortune.com","headline":"Quest Diagnostics (DGX): Company Profile, Stock Price, News, Rankings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPbnozVUpqUkxacmN3Y3BjWWxYSnFGTnZFX2czelZaM0NSdkk0RFdWNlp6T0FRZjY3c3J5Sm5vc2ZST3NEb2dpdjVwVE1kZzExdWVZbHcwTHhrMk1qYjl4V1g3Z0tCOHoxVFhpWE5FSVlHSUtBWDhsdjMtbUJ3MFpYcmNGc1pXS0NJSHlJaGNrMWpOTnlBWTh1UVNZcUg3T1ZQYWhieA?oc=5","date":"2020-04-28","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Quest Diagnostics launches patient-ordered COVID-19 antibody test - drugdiscoverytrends.com","headline":"Quest Diagnostics launches patient-ordered COVID-19 antibody test","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["LabCorp","BioReference Laboratories","Sema4 Holdings Corporation"],"therapeuticFocus":["Clinical Laboratory Services"],"financials":{"source":"sec_edgar+yahoo","revenue":11035000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":11035000000,"period":"2025-12-31"},{"value":9872000000,"period":"2024-12-31"},{"value":9872000000,"period":"2024-12-31"},{"value":9252000000,"period":"2023-12-31"},{"value":9252000000,"period":"2023-12-31"}],"grossProfit":3665000000,"grossProfitHistory":[{"period":"2025-12-31","value":3665000000},{"period":"2024-12-31","value":3244000000},{"period":"2023-12-31","value":3053000000},{"period":"2022-12-31","value":3433000000}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":1967000000,"operatingIncome":1556000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":1556000000},{"period":"2024-12-31","value":1346000000},{"period":"2023-12-31","value":1262000000},{"period":"2022-12-31","value":1428000000}],"netIncome":992000000,"netIncomeHistory":[{"period":"2025-12-31","value":992000000},{"period":"2024-12-31","value":871000000},{"period":"2023-12-31","value":854000000},{"period":"2022-12-31","value":946000000}],"eps":8.75,"epsHistory":[{"period":"2025-12-31","value":8.75},{"period":"2024-12-31","value":7.69},{"period":"2023-12-31","value":7.49},{"period":"2022-12-31","value":7.97}],"cash":420000000,"cashHistory":[{"period":"2025-12-31","value":420000000},{"period":"2024-12-31","value":549000000},{"period":"2023-12-31","value":686000000},{"period":"2022-12-31","value":315000000}],"totalAssets":16225000000,"totalLiabilities":8939000000,"totalDebt":6585000000,"equity":7170000000,"operatingCashflow":1886000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":1886000000},{"period":"2024-12-31","value":1334000000},{"period":"2023-12-31","value":1272000000},{"period":"2022-12-31","value":1718000000}],"capex":-527000000,"capexHistory":[{"period":"2025-12-31","value":-527000000},{"period":"2024-12-31","value":-425000000},{"period":"2023-12-31","value":-408000000},{"period":"2022-12-31","value":-404000000}],"freeCashflow":1359000000,"dividendsPaid":-353000000,"buybacks":-450000000,"employees":57000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":499000000,"ebit":399000000,"ebitda":546000000,"period":"2026-03-31","revenue":2895000000,"epsBasic":2.27,"netIncome":252000000,"rdExpense":null,"epsDiluted":2.24,"grossProfit":942000000,"operatingIncome":404000000},{"sga":504000000,"ebit":397000000,"ebitda":542000000,"period":"2025-12-31","revenue":2806000000,"epsBasic":2.21,"netIncome":245000000,"rdExpense":null,"epsDiluted":2.18,"grossProfit":910000000,"operatingIncome":386000000},{"sga":501000000,"ebit":397000000,"ebitda":539000000,"period":"2025-09-30","revenue":2816000000,"epsBasic":2.18,"netIncome":245000000,"rdExpense":null,"epsDiluted":2.16,"grossProfit":949000000,"operatingIncome":386000000},{"sga":486000000,"ebit":453000000,"ebitda":596000000,"period":"2025-06-30","revenue":2761000000,"epsBasic":2.51,"netIncome":282000000,"rdExpense":null,"epsDiluted":2.47,"grossProfit":943000000,"operatingIncome":438000000},{"sga":471000000,"ebit":348000000,"ebitda":488000000,"period":"2025-03-31","revenue":2652000000,"epsBasic":1.97,"netIncome":220000000,"rdExpense":null,"epsDiluted":1.94,"grossProfit":863000000,"operatingIncome":351000000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":188.99,"previousClose":190.85,"fiftyTwoWeekHigh":213.5,"fiftyTwoWeekLow":164.65,"fiftyTwoWeekRange":"164.65 - 213.5","fiftyDayAverage":196.13,"twoHundredDayAverage":187.22,"beta":0.59,"enterpriseValue":27520413696,"forwardPE":16.2,"priceToBook":2.85,"priceToSales":1.85,"enterpriseToRevenue":2.44,"enterpriseToEbitda":12.36,"pegRatio":1.44,"ebitda":2225999872,"ebitdaMargin":19.7,"freeCashflow":947875008,"operatingCashflow":1850000000,"totalDebt":6408000000,"debtToEquity":82.7,"currentRatio":1.18,"returnOnAssets":6.3,"returnOnEquity":14.5,"analystRating":"2.1 - Buy","recommendationKey":"buy","numberOfAnalysts":16,"targetMeanPrice":223.25,"targetHighPrice":245,"targetLowPrice":184,"dividendRate":3.44,"payoutRatio":0.36,"fiveYearAvgDividendYield":1.85,"exDividendDate":1775433600,"insiderHeldPercent":0.4,"institutionHeldPercent":98.2,"sharesOutstanding":110696429,"floatShares":110080957,"sharesShort":3389572,"shortRatio":3.21,"shortPercentOfFloat":3.1,"epsTrailing":9.05,"epsForward":11.67,"revenuePerShare":101.83,"bookValue":66.36,"officers":[{"age":62,"name":"Mr. James E. Davis","title":"Chairman, CEO & President"},{"age":55,"name":"Mr. Sam A. Samad","title":"Executive VP & CFO"},{"age":63,"name":"Mr. Michael E. Prevoznik J.D.","title":"Senior VP & General Counsel"},{"age":62,"name":"Ms. Catherine T. Doherty","title":"Executive Vice President of Regional Businesses"},{"age":55,"name":"Mr. Karthik  Kuppusamy Ph.D.","title":"Senior Vice President of Clinical Solutions"},{"age":58,"name":"Mr. Michael J. Deppe","title":"Senior VP, Corporate Controller & Chief Accounting Officer"},{"age":null,"name":"Mr. Murali  Balakumar","title":"Senior VP and Chief Information & Digital Officer"},{"age":null,"name":"Dan  Haemmerle","title":"Interim VP of Investor Relations & VP Finance"}],"industry":"Diagnostics & Research","irWebsite":"http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-stockquote","website":"https://www.questdiagnostics.com","phone":"973 520 2700"}}